Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial

Wajja A., Nassanga B., Natukunda A., Serubanja J., Tumusiime J., Akurut H., Oduru G., Nassuuna J., Kabagenyi J., Morrison H., Scott H., Doherty RP., Marshall JL., Puig IC., Cose S., Kaleebu P., Webb EL., Satti I., McShane H., Elliott AM., Namutebi M., Nakazibwe E., Onen C., Apuule B., Akello F., Mukasa M., Nnaluwooza M., Sewankambo M., Kiwanuka S., Kiwudhu F., Imede E., Nkurunungi G., Nakawungu PK., Kabami G., Nuwagaba E., Akello M.

DOI

10.1016/s1473-3099(23)00501-7

Type

Journal article

Journal

The Lancet Infectious Diseases

Publisher

Elsevier BV

Publication Date

03/2024

Volume

24

Pages

285 - 296

Permalink Original publication